Understanding how the p53 protein behaves in cancer cells
Dynamics, Regulation and Function of p53 in Single Cells
This study is looking at how a protein called p53 behaves in cancer cells and how its actions are affected by the environment around the tumor, with the hope of using this knowledge to make cancer treatments better for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10997326 on NIH RePORTER |
What this research studies
This research investigates the behavior of the p53 protein, a crucial factor in controlling cell survival and death in response to stress, particularly in cancer cells. By examining how p53 dynamics are influenced by the cellular environment, such as the 3D structure of tumors, the study aims to uncover how these dynamics affect gene expression and cellular outcomes. The research employs advanced techniques like live imaging and single-cell RNA sequencing to gain insights into the role of p53 in cancer therapy. Ultimately, the goal is to leverage this understanding to improve cancer treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancers that involve mutations in the p53 gene or those undergoing treatments that affect p53 dynamics.
Not a fit: Patients with cancers unrelated to p53 mutations or those not currently receiving treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer therapies by optimizing the use of p53 dynamics in treatment strategies.
How similar studies have performed: Previous research has shown promising results in understanding p53 dynamics, suggesting that this approach could lead to significant advancements in cancer treatment.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Lahav, Galit — Harvard Medical School
- Study coordinator: Lahav, Galit
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.